810106C

NBD AA

Avanti Research^™ - A Croda Brand 810106C

• 别名: 20-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] arachidonic acid
• 经验公式（希尔记法）: C₂₆H₃₄ N₄O₅
• CAS号: 2254005-15-5
• 分子量: 482.57
• 分類程式碼代碼: 12352211
• NACRES: NA.25

属性

• 化驗: >99% (TLC)
• 形狀: liquid
• 包裝: pkg of 1 × 1 mL (810106C-1mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 810106C
• 濃度: 1 mg/mL (810106C-1mg)
• 脂質類型: fluorescent lipids; bioactive lipids
• 運輸包裝: dry ice
• 儲存溫度: −70°C

说明

一般說明

The endocannabinoid pathway influences behavior, lipogenesis, embryologic development, and pathophysiological effects including pain, inflammation, stress, obesity, and non-alcoholic fatty liver disease. Endogenous endocannabinoids including arachidonoylethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) are derived from arachidonic acid (AA). Fluorescent NBD-AA and NBD-AEA analogues are direct probes that can be used for visualizing the uptake, intracellular trafficking, and targeting of these molecules by living cells, as well as measuring the binding of endocannabinoids to cytosolic binding proteins. Importantly, direct binding studies show the affinities of the fluorescent analogues are in the same range as the respective unlabeled ligands. Fluorescent endocannabinoid probes are useful for mapping the impact of various treatments, inhibitors, etc on endocannabinoid uptake and distribution in living cells.

包裝

5 mL Amber Glass Screw Cap Vial/Argon/Foil Bag 810106C-1mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全信息

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H302,H315,H319,H331,H336,H351,H361d,H372
• 防範說明: P260 - P280 - P301 + P312 + P330 - P304 + P340 + P311 - P305 + P351 + P338 - P403 + P233
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 標靶器官: Central nervous system
• 水污染物質分類（WGK）: WGK 3